We support early stage biotechnology businesses in a wide range of sectors ranging from DNA sequencing to innovative solid dose drug delivery systems.
We are always interested in technology that can satisfy unmet medical needs in the fields of pharmaceuticals, biotechnology, and medical technology (medical devices).
With increasing life expectancy, increased pollution and a rise in the global population many observers are looking to biotechnology as a panacea for problems ranging from fuel and food shortages to water pollution and drug resistance.
At Meridian we have a keen interest in supporting ventures that have new technologies with the opportunity to change the status quo. Please look at our current investment in Glide Pharmaceuticals to see an example of a ground breaking technology we are supporting.